Literature DB >> 15226925

Cyclosporin A: a new advance in transplantation.

B D Kahan1.   

Abstract

Cyclosporin A (CyA)* has been shown to be a cytostatic drug with apparent specificity for the immune system. At clinical trials, an analysis of the patients showed marked immunosuppressive potency of CyA. This selective anti-T cell agent is described in detail, with studies showing the immunological effects of graft survival in renal transplant patients.

Entities:  

Year:  1982        PMID: 15226925      PMCID: PMC351624     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  28 in total

1.  Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.

Authors:  J F Borel
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

2.  Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

3.  High-performance liquid chromatographic determination of cyclosporin A in human plasma and urine.

Authors:  W Niederberger; P Schaub; T Beveridge
Journal:  J Chromatogr       Date:  1980-06-13

4.  Cyclosporin A hepatotoxicity in 66 renal allograft recipients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Transplantation       Date:  1981-12       Impact factor: 4.939

5.  Cyclosporin receptor on mouse lymphocytes.

Authors:  B Ryffel; P Donatsch; U Götz; M Tschopp
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

6.  Macrophage-related suppressor cells in human renal transplant recipients.

Authors:  J Thomas; F Thomas; S Hoffmann; C Johns; H M Lee
Journal:  Surgery       Date:  1979-08       Impact factor: 3.982

7.  Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro.

Authors:  T Paavonen; P Häyry
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

8.  Immune responses to organ allografts. III. Marked decrease in medullary thymocytes and splenic T lymphocytes after cyclosporin A treatment.

Authors:  W M Baldwin; I F Hutchinson; C J Meijer; N L Tilney
Journal:  Transplantation       Date:  1981-02       Impact factor: 4.939

9.  Immunosuppressive properties of cyclosporin A (CY-A).

Authors:  J F Borel
Journal:  Transplant Proc       Date:  1980-06       Impact factor: 1.066

10.  Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.

Authors:  A B Cosimi; R B Colvin; R C Burton; R H Rubin; G Goldstein; P C Kung; W P Hansen; F L Delmonico; P S Russell
Journal:  N Engl J Med       Date:  1981-08-06       Impact factor: 91.245

View more
  4 in total

1.  Cardiopulmonary allotransplantation, a collective review: experimental progress and current clinical status.

Authors:  G A Painvin; I J Reece; D A Cooley; O H Frazier
Journal:  Tex Heart Inst J       Date:  1983-12

2.  Martyrdom for scientific purpose.

Authors:  D A Cooley
Journal:  Tex Heart Inst J       Date:  1983-06

3.  Solid-phase enrichment and analysis of electrophilic natural products.

Authors:  Frank Wesche; Yue He; Helge B Bode
Journal:  Beilstein J Org Chem       Date:  2017-03-02       Impact factor: 2.883

4.  Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels.

Authors:  Yijun Wu; Jing Yao; Jianping Zhou; Fatima Zohra Dahmani
Journal:  Int J Nanomedicine       Date:  2013-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.